HAVCR1 and neoplasm: Tumor-bearing mice received 15 days of treatment with (i) IgG control, (ii) STING agonist with IgG, (iii) anti-TIM-1 antibody, or (iv) STING agonist with anti-TIM-1 antibody (Fig. S9A).